NewSquare Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.85M | Sell |
137,002
-1,635
| -1% | -$43.5K | 0.33% | 96 |
|
|
2025
Q4 | $3.45M | Sell |
138,637
-21,172
| -13% | -$534K | 0.3% | 89 |
|
|
2025
Q3 | $4.07M | Sell |
159,809
-2,171
| -1% | -$53.6K | 0.28% | 99 |
|
|
2025
Q2 | $3.88M | Buy |
161,980
+6,832
| +4% | +$159K | 0.29% | 95 |
|
|
2025
Q1 | $3.88M | Buy |
155,148
+493
| +0.3% | +$12.9K | 0.32% | 92 |
|
|
2024
Q4 | $4.05M | Sell |
154,655
-1,109
| -0.7% | -$30.1K | 0.32% | 94 |
|
|
2024
Q3 | $4.45M | Sell |
155,764
-1,770
| -1% | -$51.6K | 0.35% | 96 |
|
|
2024
Q2 | $4.35M | Buy |
157,534
+4,956
| +3% | +$136K | 0.37% | 91 |
|
|
2024
Q1 | $4.18M | Buy |
152,578
+5,132
| +3% | +$142K | 0.37% | 87 |
|
|
2023
Q4 | $4.19M | Buy |
147,446
+4,354
| +3% | +$132K | 0.4% | 89 |
|
|
2023
Q3 | $4.68M | Buy |
143,092
+4,817
| +3% | +$170K | 0.49% | 63 |
|
|
2023
Q2 | $5.07M | Sell |
138,275
-3,879
| -3% | -$151K | 0.53% | 70 |
|
|
2023
Q1 | $5.8M | Buy |
142,154
+13,915
| +11% | +$601K | 0.69% | 51 |
|
|
2022
Q4 | $6.57M | Buy |
128,239
+7,614
| +6% | +$365K | 0.82% | 35 |
|
|
2022
Q3 | $5.28M | Buy |
120,625
+7,220
| +6% | +$351K | 0.66% | 43 |
|
|
2022
Q2 | $5.95M | Buy |
113,405
+20,284
| +22% | +$1.03M | 0.76% | 38 |
|
|
2022
Q1 | $4.82M | Buy |
93,121
+10,238
| +12% | +$531K | 0.51% | 49 |
|
|
2021
Q4 | $4.89M | Buy |
82,883
+7,800
| +10% | +$386K | 0.52% | 40 |
|
|
2021
Q3 | $3.23M | Buy |
75,083
+526
| +0.7% | +$23.3K | 0.38% | 75 |
|
|
2021
Q2 | $2.92M | Buy |
74,557
+3,918
| +6% | +$152K | 0.35% | 81 |
|
|
2021
Q1 | $2.56M | Buy |
70,639
+5,104
| +8% | +$181K | 0.34% | 85 |
|
|
2020
Q4 | $2.41M | Sell |
65,535
-2,546
| -4% | -$93.4K | 0.34% | 85 |
|
|
2020
Q3 | $2.37M | Buy |
68,081
+4,400
| +7% | +$154K | 0.38% | 67 |
|
|
2020
Q2 | $1.98M | Buy |
63,681
+281
| +0.4% | +$9.55K | 0.34% | 67 |
|
|
2020
Q1 | $1.96M | Buy |
63,400
+3,867
| +6% | +$132K | 0.36% | 56 |
|
|
2019
Q4 | $2.21M | Buy |
59,533
+5,529
| +10% | +$197K | 0.37% | 55 |
|
|
2019
Q3 | $1.84M | Buy |
54,004
+1,746
| +3% | +$63.5K | 0.33% | 62 |
|
|
2019
Q2 | $2.15M | Buy |
52,258
+942
| +2% | +$37.4K | 0.39% | 41 |
|
|
2019
Q1 | $2.07M | Sell |
51,316
-816
| -2% | -$32.7K | 0.39% | 37 |
|
|
2018
Q4 | $2.16M | Sell |
52,132
-722
| -1% | -$30K | 0.46% | 34 |
|
|
2018
Q3 | $2.21M | Buy |
52,854
+2,691
| +5% | +$104K | 0.42% | 37 |
|
|
2018
Q2 | $1.78M | Buy |
50,163
+6,062
| +14% | +$207K | 0.36% | 46 |
|
|
2018
Q1 | $1.49M | Sell |
44,101
-1,170
| -3% | -$40.2K | 0.32% | 48 |
|
|
2017
Q4 | $1.56M | Sell |
45,271
-79,272
| -64% | -$2.7M | 0.36% | 44 |
|
|
2017
Q3 | $1.45M | Buy |
124,543
+82,734
| +198% | +$2.66M | 0.35% | 41 |
|
|
2017
Q2 | $1.33M | Buy |
41,809
+2,035
| +5% | +$64.2K | 0.32% | 45 |
|
|
2017
Q1 | $1.29M | Buy |
39,774
+5,550
| +16% | +$175K | 0.31% | 46 |
|
|
2016
Q4 | $1.05M | Buy |
34,224
+909
| +3% | +$27.8K | 0.26% | 59 |
|
|
2016
Q3 | $1.07M | Buy |
33,315
+1,290
| +4% | +$43.1K | 0.25% | 55 |
|
|
2016
Q2 | $1.07M | Buy |
32,025
+8,038
| +34% | +$257K | 0.25% | 52 |
|
|
2016
Q1 | $675K | Sell |
23,987
-782
| -3% | -$22.3K | 0.19% | 80 |
|
|
2015
Q4 | $759K | Buy |
24,769
+866
| +4% | +$27.2K | 0.21% | 62 |
|
|
2015
Q3 | $712K | Sell |
23,903
-231
| -1% | -$7.41K | 0.21% | 56 |
|
|
2015
Q2 | $768K | Buy |
24,134
+1,046
| +5% | +$34.1K | 0.23% | 64 |
|
|
2015
Q1 | $762K | Buy |
23,088
+1,076
| +5% | +$34.2K | 0.23% | 55 |
|
|
2014
Q4 | $651K | Buy |
22,012
+2,003
| +10% | +$57.4K | 0.22% | 68 |
|
|
2014
Q3 | $561K | Buy |
20,009
+2,268
| +13% | +$63.7K | 0.2% | 84 |
|
|
2014
Q2 | $500K | Buy |
17,741
+2,169
| +14% | +$61.8K | 0.18% | 81 |
|
|
2014
Q1 | $475K | Buy |
15,572
+372
| +2% | +$11.1K | 0.19% | 77 |
|
|
2013
Q4 | $442K | Buy |
15,200
+958
| +7% | +$27.9K | 0.21% | 61 |
|
|
2013
Q3 | $388K | Buy |
14,242
+172
| +1% | +$4.68K | 0.19% | 64 |
|
|
2013
Q2 | $374K | Buy |
+14,070
| New | +$389K | 0.18% | 66 |
|
Other funds holding PFE
VCM
VPM
NewSquare Capital's PFE Position: Q1 2026 in Review
NewSquare Capital reduced its Pfizer (PFE) stake by 1.2% in Q1 2026, selling an estimated $43.5K and leaving 137,002 shares worth $3.85M. The position accounts for 0.33% of the portfolio, ranked #96.
NewSquare Capital first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.57M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- NewSquare Capital held 137,002 shares of Pfizer worth $3.85M as of Q1 2026.
- NewSquare Capital sold 1,635 Pfizer shares in Q1 2026, an estimated $43.5K.
- Pfizer made up 0.33% of NewSquare Capital's portfolio in Q1 2026, its #96 holding.
- NewSquare Capital first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- NewSquare Capital's Pfizer position peaked at $6.57M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on NewSquare Capital's 13F filing for Q1 2026, filed 8 May 2026.